Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AtriCure Inc gives Q4 2013 revenue guidance above analysts' estimates; updates on FY 2013 revenue guidance; gives FY 2014 guidance; revenue guidance above analysts' estimates


Thursday, 9 Jan 2014 04:00pm EST 

AtriCure Inc:Says Q4 2013 preliminary revenue to be about $21.9 million.Says FY 2013 preliminary revenue to be $81.9 million.Says FY 2014 revenue to be in the range of $100 million to $103 million.Says FY 2014 adjusted EBITDA, a non-GAAP measure, to be a loss in the range of $9 to $10 million.Q4 2013 revenue of $20.07 million - Thomson Reuters I/B/E/S Estimates.FY 2013 revenue of $80.09 million - Thomson Reuters I/B/E/S Estimates.FY 2014 revenue of $90 million and EBITDA of $(9) million - Thomson Reuters I/B/E/S Estimates. 

Company Quote

21.2
0.14 +0.66%
27 Mar 2015